A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma - Response

被引：21

作者：

Mazzaferri, EL

Robbins, RJ

Braverman, LE

Pacini, F

Haugen, B

Wartofsky, L

Braunstein, GD

Ladenson, PW

Pinchera, A

机构：

[1] FL

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2003年 / 88卷 / 09期

关键词：

D O I：

10.1210/jc.2003-031041

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：4508 / 4510

页数：3

共 7 条

[1] A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer [J].

Haugen, BR ;

Pacini, F ;

Reiners, C ;

Schlumberger, M ;

Ladenson, PW ;

Sherman, SI ;

Cooper, DS ;

Graham, KE ;

Braverman, LE ;

Skarulis, MC ;

Davies, TF ;

DeGroot, LJ ;

Mazzaferri, EL ;

Daniels, GH ;

Ross, DS ;

Luster, M ;

Samuels, MH ;

Becker, DV ;

Maxon, HR ;

Cavalieri, RR ;

Spencer, CA ;

McEllin, K ;

Weintraub, BD ;

Ridgway, EC .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :3877-3885

[2] Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): Temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients [J].

Hay, ID ;

Thompson, GB ;

Grant, CS ;

Bergstralh, EJ ;

Dvorak, CE ;

Gorman, CA ;

Maurer, MS ;

McIver, B ;

Mullan, BP ;

Oberg, AL ;

Powell, CC ;

van Heerden, JA ;

Goellner, JR .

WORLD JOURNAL OF SURGERY, 2002, 26 (08) :879-885

[3] Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer [J].

Hooft, L ;

Hoekstra, OS ;

Devillé, W ;

Lips, P ;

Teule, GJJ ;

Boers, M ;

van Tulder, MW .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) :3779-3786

[4]

Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO

[5]

2-1

[6] Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma [J].

Ladenson, PW ;

Braverman, LE ;

Mazzaferri, EL ;

BruckerDavis, F ;

Cooper, DS ;

Garber, JR ;

Wondisford, FE ;

Davies, TF ;

DeGroot, LJ ;

Daniels, GH ;

Ross, DS ;

Weintraub, BD .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (13) :888-896

[7]

Ries LA., 2000, SEER CANC STAT REV 1

← 1 →